LIVE FROM THE DATABASETRANSACTIONS 362,430COMPANIES 5,763LATEST TRADE Oct 16UPDATED Oct 17, 12:31 AM
VYNECIK 0001566044

VYNE Therapeutics Inc.

19 transactions by 6 insiders, from December 12, 2025 to July 23, 2026.

Transactions
196 insiders
Bought · P
Nonenobody bought on the open market
Sold · S
Nonenobody sold on the open market
Net
+$0net buying

Officers and directors

People inside the company. What they do with their own shares is the reason this data exists.

InsiderTradesPlannedBoughtSold
David DomzalskiCEO5———
Iain StuartChief4———
Mutya HarschGC4———
Tyler ZerondaCFO4———
Sharon BarbariDir1———
Steven L. BastaDir1———

All transactions

19 in total, newest filings first.

InsiderDateCodeSharesPriceValue
Tyler ZerondaCFOJul 23F22,516$0.90$20K
Iain StuartChiefJul 23F15,405$0.90$14K
Mutya HarschGCJul 23F22,516$0.90$20K
David DomzalskiCEOJul 23F79,391$0.90$71K
Tyler ZerondaCFOJun 30F3,464$0.65$2K
Iain StuartChiefJun 30F2,370$0.65$2K
Mutya HarschGCJun 30F3,464$0.65$2K
David DomzalskiCEOJun 30F12,214$0.65$8K
David DomzalskiCEOMay 29A30,791$0.31$10K
Tyler ZerondaCFOMar 31F4,007$0.60$2K
Iain StuartChiefMar 31F2,876$0.60$2K
Mutya HarschGCMar 31F4,007$0.60$2K
David DomzalskiCEOMar 31F14,232$0.60$9K
Tyler ZerondaCFODec 31F7,858$0.58$5K
Iain StuartChiefDec 31F2,448$0.58$1K
Mutya HarschGCDec 31F3,579$0.58$2K
David DomzalskiCEODec 31F12,684$0.58$7K
Steven L. BastaDirDERIVDec 12A20,000$0.00—?
Sharon BarbariDirDERIVDec 12A20,000$0.00—?